全球预测毒理学人工智慧市场研究报告 - 产业分析、规模、份额、成长、趋势及 2025 年至 2033 年预测

全球预测毒理学人工智慧市场预计将大幅成长，到 2033 年将达到 53.7 亿美元，高于 2024 年的 5 亿美元。预计 2025 年至 2033 年期间该市场的年复合成长率(CAGR) 为 30.04%。

随着机器学习演算法和巨量资料分析提升毒性评估的准确性和速度，预测毒理学市场的人工智慧正在经历快速转型。透过利用大量的化学和生物资料集，人工智慧模型能够及早识别毒理学风险，减少对动物试验的依赖，并加快药物研发流程。深度学习技术与电脑模拟模拟的结合，正在以前所未有的精度预测复杂的毒理学终点，包括遗传毒性和免疫毒性。这项技术进步对于药品、化学品和消费品的合规性和安全性评估至关重要。

此外，人工智慧与高通量筛选和组学技术的融合正在产生多维资料集，这些资料集可以完善预测模型，并支援对毒性途径的机制理解。基于云端的平台和协作数据共享计划正在使人工智慧工具的使用更加普及，促进毒理学评估的创新和标准化。随着监管机构越来越多地认可人工智慧驱动的方法，市场有望加速采用，从而推动更安全的产品开发并缩短新化合物的上市时间。

我们的报告经过精心设计，旨在为客户提供关于各个行业和市场的全面且切实可行的洞察。每份报告都包含几个关键部分，以确保客户全面了解市场格局：

市场概况：对市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本部分探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准，将市场细分为不同的细分市场。此分析重点在于突出每个细分市场的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本部分深入分析了领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，对特定时期的市场规模和成长趋势进行预测。这包括定量分析和图形表示，以说明未来的市场发展轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前及新兴市场趋势、技术创新和潜在投资领域。本部分提供对未来市场发展和成长前景的洞察。

涵盖的细分市场列表

预测毒理学人工智慧市场报告的此部分提供了国家和地区层面的详细资料，从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。

按组件

• 解决方案
• 服务

依技术

• 机器学习
• 自然语言处理
• 电脑视觉
• 其他的

按毒性终点

• 遗传毒性
• 肝毒性
• 神经毒性
• 心臟毒性
• 其他的

按最终用户

• 製药和生物技术公司
• 化学物质和化妆品
• 合约研究组织
• 其他的
• 报告中介绍的公司列表
• Benevolent AI、Berg Health、Biovista、Celsius Therapeutics、Chemaxon Ltd.、Cyclica、Exscientia PLC、Insilico Medicine、Instem plc、Lhasa Limited、Recursion Pharmaceuticals。

如果您有任何客製化需求，请联络我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告描述
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究流程
  • 市场研究方法

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第三章：预测毒理学中的人工智慧—产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业趋势
• 波特五力分析
• 市场吸引力分析
  • 各组成部分的市场吸引力分析
  • 按技术分析市场吸引力
  • 按毒性终点进行的市场吸引力分析
  • 按最终用户进行的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料製造商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第五章：全球预测毒理学人工智慧市场分析：按组成部分

• 按组件概览
• 按组件进行历史和预测资料分析
• 解决方案
• 服务

第六章：全球预测毒理学人工智慧市场分析：按技术

• 依技术概览
• 按技术进行历史和预测数据分析
• 机器学习
• 自然语言处理
• 电脑视觉
• 其他的

第七章：全球预测毒理学人工智慧市场分析：按毒性终点

• 按毒性终点概述
• 按毒性终点进行历史和预测数据分析
• 遗传毒性
• 肝毒性
• 神经毒性
• 心臟毒性
• 其他的

第 8 章：全球预测毒理学人工智慧市场分析：按最终用户

• 最终用户概览
• 最终用户的历史和预测数据分析
• 製药和生物技术公司
• 化学物质和化妆品
• 合约研究组织
• 其他的

第九章：全球预测毒理学人工智慧市场分析：按地区

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美各细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲各细分市场销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区分部销售分析
  • 亚太地区国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲分部销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第 10 章：预测毒理学公司人工智慧的竞争格局

• 预测毒理学市场竞争中的人工智慧
• 伙伴关係/合作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Benevolent AI
• 公司概况
• 公司收入
• 产品
• 最新动态
• Berg Health
• 公司概况
• 公司收入
• 产品
• 最新动态
• Biovista
• 公司概况
• 公司收入
• 产品
• 最新动态
• Celsius Therapeutics
• 公司概况
• 公司收入
• 产品
• 最新动态
• Chemaxon Ltd.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Cyclica
• 公司概况
• 公司收入
• 产品
• 最新动态
• Exscientia PLC
• 公司概况
• 公司收入
• 产品
• 最新动态
• Insilico Medicine
• 公司概况
• 公司收入
• 产品
• 最新动态
• Instem Plc
• 公司概况
• 公司收入
• 产品
• 最新动态
• Lhasa Limited
• 公司概况
• 公司收入
• 产品
• 最新动态
• Recursion Pharmaceuticals
• 公司概况
• 公司收入
• 产品
• 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

Global AI In Predictive Toxicology Market is poised to witness substantial growth, reaching a value of USD 5.37 Billion by the year 2033, up from USD 0.5 Billion attained in 2024. The market is anticipated to display a Compound Annual Growth Rate (CAGR) of 30.04% between 2025 and 2033.

The AI in predictive toxicology market is undergoing rapid transformation as machine learning algorithms and big data analytics enhance the accuracy and speed of toxicity assessments. By leveraging vast chemical and biological datasets, AI models are enabling early identification of toxicological risks, reducing reliance on animal testing and expediting drug development pipelines. The integration of deep learning techniques with in silico modeling is facilitating the prediction of complex toxicological endpoints, including genotoxicity and immunotoxicity, with unprecedented precision. This technological advancement is critical for regulatory compliance and safety evaluation across pharmaceuticals, chemicals, and consumer products.

Furthermore, the convergence of AI with high-throughput screening and omics technologies is generating multidimensional datasets that refine predictive models and support mechanistic understanding of toxicity pathways. Cloud-based platforms and collaborative data-sharing initiatives are democratizing access to AI tools, fostering innovation and standardization in toxicology assessments. As regulatory agencies increasingly endorse AI-driven methodologies, the market is poised for accelerated adoption, driving safer product development and reducing time-to-market for novel compounds.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the AI In Predictive Toxicology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component

• Solution
• Services

By Technology

• Machine Learning
• Natural Language Processing
• Computer Vision
• Others

By Toxicity Endpoints

• Genotoxicity
• Hepatotoxicity
• Neurotoxicity
• Cardiotoxicity
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Chemical & Cosmetics
• Contract Research Organizations
• Others
• List of Companies Profiled in the report
• Benevolent AI, Berg Health, Biovista, Celsius Therapeutics, Chemaxon Ltd., Cyclica, Exscientia PLC, Insilico Medicine, Instem plc, Lhasa Limited, Recursion Pharmaceuticals.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. AI IN PREDICTIVE TOXICOLOGY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Component
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By Toxicity Endpoints
  • 3.7.4 Market Attractiveness Analysis By End User
  • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY COMPONENT

• 5.1. Overview By Component
• 5.2. Historical and Forecast Data Analysis By Component
• 5.3. Solution Historic and Forecast Sales By Regions
• 5.4. Services Historic and Forecast Sales By Regions

6. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY TECHNOLOGY

• 6.1. Overview By Technology
• 6.2. Historical and Forecast Data Analysis By Technology
• 6.3. Machine Learning Historic and Forecast Sales By Regions
• 6.4. Natural Language Processing Historic and Forecast Sales By Regions
• 6.5. Computer Vision Historic and Forecast Sales By Regions
• 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY TOXICITY ENDPOINTS

• 7.1. Overview By Toxicity Endpoints
• 7.2. Historical and Forecast Data Analysis By Toxicity Endpoints
• 7.3. Genotoxicity Historic and Forecast Sales By Regions
• 7.4. Hepatotoxicity Historic and Forecast Sales By Regions
• 7.5. Neurotoxicity Historic and Forecast Sales By Regions
• 7.6. Cardiotoxicity Historic and Forecast Sales By Regions
• 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY END USER

• 8.1. Overview By End User
• 8.2. Historical and Forecast Data Analysis By End User
• 8.3. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
• 8.4. Chemical & Cosmetics Historic and Forecast Sales By Regions
• 8.5. Contract Research Organizations Historic and Forecast Sales By Regions
• 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE AI IN PREDICTIVE TOXICOLOGY COMPANIES

• 10.1. AI In Predictive Toxicology Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF AI IN PREDICTIVE TOXICOLOGY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Benevolent AI
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Berg Health
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Biovista
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Celsius Therapeutics
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Chemaxon Ltd.
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Cyclica
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Exscientia PLC
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Insilico Medicine
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Instem Plc
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Lhasa Limited
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Recursion Pharmaceuticals
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Component (USD MN)
• Solution Market Sales By Geography (USD MN)
• Services Market Sales By Geography (USD MN)
• Analysis By Technology (USD MN)
• Machine Learning Market Sales By Geography (USD MN)
• Natural Language Processing Market Sales By Geography (USD MN)
• Computer Vision Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By Toxicity Endpoints (USD MN)
• Genotoxicity Market Sales By Geography (USD MN)
• Hepatotoxicity Market Sales By Geography (USD MN)
• Neurotoxicity Market Sales By Geography (USD MN)
• Cardiotoxicity Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By End User (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
• Chemical & Cosmetics Market Sales By Geography (USD MN)
• Contract Research Organizations Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global AI In Predictive Toxicology Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of AI In Predictive Toxicology Report
• Market Research Process
• Market Research Methodology
• Global AI In Predictive Toxicology Market Size, By Regions (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Component
• Market Attractiveness Analysis By Technology
• Market Attractiveness Analysis By Toxicity Endpoints
• Market Attractiveness Analysis By End User
• Market Attractiveness Analysis By Regions
• Value Chain Analysis
• Global Market Analysis By Component (USD MN)
• Solution Market Sales By Geography (USD MN)
• Services Market Sales By Geography (USD MN)
• Global Market Analysis By Technology (USD MN)
• Machine Learning Market Sales By Geography (USD MN)
• Natural Language Processing Market Sales By Geography (USD MN)
• Computer Vision Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By Toxicity Endpoints (USD MN)
• Genotoxicity Market Sales By Geography (USD MN)
• Hepatotoxicity Market Sales By Geography (USD MN)
• Neurotoxicity Market Sales By Geography (USD MN)
• Cardiotoxicity Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By End User (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
• Chemical & Cosmetics Market Sales By Geography (USD MN)
• Contract Research Organizations Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.